rs909531

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001002294.3(FMO3):​c.1183+35T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.198 in 1,419,972 control chromosomes in the GnomAD database, including 30,028 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 4675 hom., cov: 32)
Exomes 𝑓: 0.19 ( 25353 hom. )

Consequence

FMO3
NM_001002294.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0140

Publications

11 publications found
Variant links:
Genes affected
FMO3 (HGNC:3771): (flavin containing dimethylaniline monoxygenase 3) Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. The human FMO gene family is composed of 5 genes and multiple pseudogenes. FMO members have distinct developmental- and tissue-specific expression patterns. The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals. This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry. This transmembrane protein localizes to the endoplasmic reticulum of many tissues. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor. In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.[provided by RefSeq, Jan 2016]
FMO3 Gene-Disease associations (from GenCC):
  • trimethylaminuria
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • severe primary trimethylaminuria
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 1-171114397-T-C is Benign according to our data. Variant chr1-171114397-T-C is described in ClinVar as Benign. ClinVar VariationId is 260064.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FMO3NM_001002294.3 linkc.1183+35T>C intron_variant Intron 7 of 8 ENST00000367755.9 NP_001002294.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FMO3ENST00000367755.9 linkc.1183+35T>C intron_variant Intron 7 of 8 1 NM_001002294.3 ENSP00000356729.4

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35134
AN:
151958
Hom.:
4663
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.362
Gnomad AMI
AF:
0.137
Gnomad AMR
AF:
0.137
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.0520
Gnomad FIN
AF:
0.237
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.198
Gnomad OTH
AF:
0.193
GnomAD2 exomes
AF:
0.178
AC:
38530
AN:
216176
AF XY:
0.171
show subpopulations
Gnomad AFR exome
AF:
0.374
Gnomad AMR exome
AF:
0.109
Gnomad ASJ exome
AF:
0.119
Gnomad EAS exome
AF:
0.187
Gnomad FIN exome
AF:
0.243
Gnomad NFE exome
AF:
0.204
Gnomad OTH exome
AF:
0.156
GnomAD4 exome
AF:
0.194
AC:
246086
AN:
1267896
Hom.:
25353
Cov.:
18
AF XY:
0.189
AC XY:
120455
AN XY:
638610
show subpopulations
African (AFR)
AF:
0.373
AC:
11169
AN:
29964
American (AMR)
AF:
0.109
AC:
4557
AN:
41968
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
2964
AN:
24674
East Asian (EAS)
AF:
0.187
AC:
7156
AN:
38166
South Asian (SAS)
AF:
0.0542
AC:
4368
AN:
80632
European-Finnish (FIN)
AF:
0.245
AC:
12729
AN:
51946
Middle Eastern (MID)
AF:
0.0620
AC:
331
AN:
5342
European-Non Finnish (NFE)
AF:
0.205
AC:
193075
AN:
941356
Other (OTH)
AF:
0.181
AC:
9737
AN:
53848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
9660
19321
28981
38642
48302
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6398
12796
19194
25592
31990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.231
AC:
35183
AN:
152076
Hom.:
4675
Cov.:
32
AF XY:
0.228
AC XY:
16956
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.362
AC:
14997
AN:
41468
American (AMR)
AF:
0.136
AC:
2083
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3472
East Asian (EAS)
AF:
0.182
AC:
942
AN:
5164
South Asian (SAS)
AF:
0.0516
AC:
249
AN:
4824
European-Finnish (FIN)
AF:
0.237
AC:
2509
AN:
10580
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.198
AC:
13452
AN:
67978
Other (OTH)
AF:
0.192
AC:
404
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1322
2644
3966
5288
6610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.202
Hom.:
1782
Bravo
AF:
0.230
Asia WGS
AF:
0.131
AC:
454
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.0
DANN
Benign
0.65
PhyloP100
-0.014
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs909531; hg19: chr1-171083537; COSMIC: COSV63008509; COSMIC: COSV63008509; API